Freeport-Mcmoran Inc (FCX) 10.74 $FCX InvestorsObserver

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Freeport-Mcmoran Inc (FCX) 10.74 $FCX

InvestorsObserver releases covered-call reports for Freeport-McMoRan, Potash Corporation of Saskatchewan, Smith & Wesson, JetBlue and Opko Health
PR Newswire - Wed Aug 31, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for FCX, JBLU, OPK, POT, and SWHC.
OPK: 9.37 (+0.04), FCX: 10.74 (+0.26), POT: 17.67 (-0.32), JBLU: 16.08 (+0.23), SWHC: 27.94 (+0.25)

Freeport (FCX) Suspends Some Operations at El Abra Mine
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:23AM CDT
Freeport-McMoRan Inc.'s (FCX) majority-controlled El Abra mine in Chile has halted some operations after a worker died due to an accident at its acid unloading terminal, according to Reuters.
FCX: 10.74 (+0.26), AU: 17.74 (+0.70), CDE: 14.82 (+1.33), NSU: 3.29 (+0.04)

Look for Shares of Freeport-McMoRan to Potentially Rebound after Yesterday's 2.37% Sell Off
Comtex SmarTrend(R) - Tue Aug 30, 12:46PM CDT
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $10.65 to a high of $10.97. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $10.80 on volume of 13.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FCX: 10.74 (+0.26)

Freeport-McMoRan (FCX) Approaches New Downside Target of $10.65
Comtex SmarTrend(R) - Tue Aug 30, 9:21AM CDT
Shares of Freeport-McMoRan (NYSE:FCX) opened today below their pivot of $10.97 and have already reached the first level of support at $10.81. Investors may be interested in a cross of the next downside pivot targets of $10.65 and $10.33.
FCX: 10.73 (+0.25)

Basic Materials Stocks Under Review -- Freeport-McMoRan, Alcoa, Century Aluminum, and Southern Copper
PR Newswire - Mon Aug 29, 6:30AM CDT
Stock-Callers.com today has issued research reports on Freeport-McMoRan Inc. (NYSE: FCX), Alcoa Inc. (NYSE: AA), Century Aluminum Co. (NASDAQ: CENX), and Southern Copper Corp. (NYSE: SCCO). These companies belong to the Basic Materials sector which is engaged in the exploration, production, and development of natural resources. On August 18, 2016, research firm Charles Schwab has held its "Market Perform" rating on the sector due to a generally positive economic condition in the U.S. and a slightly improving European economy. Learn more about these stocks by downloading their free research reports in PDF format at:
CENX: 6.31 (+0.10), SCCO: 26.35 (+0.25), AA: 10.29 (+0.16), FCX: 10.73 (+0.25), SCHW: 30.66 (-0.61)

Freeport-McMoRan (FCX) Breaks Through Support at $11.78
Comtex SmarTrend(R) - Wed Aug 24, 9:06AM CDT
Shares of Freeport-McMoRan (NYSE:FCX) have bearishly opened below the pivot of $11.99 today and have reached the first support level of $11.78. Analysts will be watching for a cross of the next downside pivot targets of $11.58 and $11.17.
FCX: 10.73 (+0.25)

Stock Market News for August 24, 2016
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 8:56AM CDT
Upbeat new-home sales data and better-than-expected European private sector data led the benchmarks to close in the green on Tuesday
JEC: 51.61 (-0.64), MDT: 87.16 (-0.16), MON: 106.00 (-1.44), PFE: 34.84 (+0.07), TREE: 95.42 (-0.27), FCX: 10.73 (+0.25), MRKT: 32.84 (+0.18), MYL: 40.22 (+0.25), BBY: 38.19 (-0.56), LEN: 46.59 (+0.03), AA: 10.29 (+0.16), CF: 25.68 (-0.26), KBH: 15.26 (-0.10), MTH: 36.00 (+0.03), TOL: 30.88 (+0.16), INTU: 110.82 (-1.25)

Watch for Freeport-McMoRan to Potentially Rebound After Falling 1.92% Yesterday
Comtex SmarTrend(R) - Mon Aug 22, 12:28PM CDT
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $11.51 to a high of $11.93. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $11.78 on volume of 12.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FCX: 10.73 (+0.25)

SmarTrend Watching for Potential Rebound in Shares of Freeport-McMoRan After 1.92% Loss
Comtex SmarTrend(R) - Mon Aug 22, 12:26PM CDT
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $11.51 to a high of $11.93. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $11.78 on volume of 12.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FCX: 10.73 (+0.25)

Zacks Industry Outlook Highlights: Rio Tinto, Vale S.A, Freeport-McMoRan and BHP Billiton
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:30AM CDT
Zacks Industry Outlook Highlights: Rio Tinto, Vale S.A, Freeport-McMoRan and BHP Billiton
BHP: 31.62 (+1.00), VALE: 5.68 (+0.08), FCX: 10.73 (+0.25), RIO: 31.57 (+0.44)

What Ails the Industrial Metals Industry?
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 4:40PM CDT
What Ails the Industrial Metals Industry?
BHP: 31.62 (+1.00), VALE: 5.68 (+0.08), FCX: 10.73 (+0.25), RIO: 31.57 (+0.44)

Zacks Industry Outlook Highlights: BHP Billiton, Rio Tinto, Vale, Alcoa and Freeport-McMoRan
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 8:30AM CDT
Zacks Industry Outlook Highlights: BHP Billiton, Rio Tinto, Vale, Alcoa and Freeport-McMoRan
AA: 10.29 (+0.16), VALE: 5.68 (+0.08), BHP: 31.62 (+1.00), FCX: 10.73 (+0.25), RIO: 31.57 (+0.44)

Industrial Metals Stock Outlook - Aug 2016
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 5:02PM CDT
Industrial Metals Stock Outlook - Aug 2016
AA: 10.29 (+0.16), BHP: 31.62 (+1.00), VALE: 5.68 (+0.08), FCX: 10.73 (+0.25), RIO: 31.57 (+0.44)

Covered Call reports for Freeport-McMoRan, GNC Holdings, BP, TASER International and Boeing include trade ideas that offer returns of 20% or more!
PR Newswire - Wed Aug 17, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for BA, BP, FCX, GNC, and TASR.
GNC: 21.01 (+0.27), FCX: 10.73 (+0.25), BP: 34.71 (+0.21), TASR: 26.40 (-0.17), BA: 132.77 (+1.61)

Analyst Reports for Macy's, Disney, ConocoPhillips & Others
Sheraz Mian - Zacks Investment Research - Tue Aug 16, 10:52AM CDT
Analyst Reports for Macy's, Disney, ConocoPhillips & Others
PRU: 78.52 (-0.97), FCX: 10.73 (+0.25), COP: 41.04 (+0.12), DIS: 93.87 (-0.55), M: 36.20 (-0.44), SCHW: 30.66 (-0.61)

Freeport-McMoRan (FCX) Crosses Pivot Point Resistance at $12.09
Comtex SmarTrend(R) - Mon Aug 15, 9:19AM CDT
Shares of Freeport-McMoRan (NYSE:FCX) opened today above their pivot of $11.91 and have already reached the first level of resistance at $12.09. Investors may be interested in a cross of the next upside pivot targets of $12.37 and $12.83.
FCX: 10.73 (+0.25)

After Yesterday's Decline of 1.57%, Freeport-McMoRan Offers Investors Better Value
Comtex SmarTrend(R) - Fri Aug 12, 12:24PM CDT
Freeport-McMoRan (NYSE:FCX) traded in a range yesterday that spanned from a low of $11.91 to a high of $12.18. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $11.93 on volume of 10.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
FCX: 10.73 (+0.25)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 5

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 5

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 8

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading

Top 5 Most Recently Viewed Articles

In-Silico Clinical Trials Expected to Surge to $6.39 Billion

Updated Category News Views 196

In-Silico Clinical Trials Market Overview The in-silico clinical trials market is witnessing substantial growth, projected to reach USD 6.39 billion in the near future. This transformation reflects a significant shift in how pharmaceutical and medical technology companies approach drug development and clinical evaluation. By leveraging advanced digital technologies,...

Continue Reading
Longeveron Inc. Announces Significant Leadership Changes

Updated Category News Views 162

Longeveron Inc. Leadership Evolution Longeveron Inc. has recently made pivotal updates to its leadership team, signaling significant strategic shifts within the company. Than Powell is stepping up as the Interim CEO, while Dr. Joshua Hare, a cornerstone of the company, takes on the role of Executive Chairman of the Board. These changes come as the company aims to enhance...

Continue Reading
Aebi Schmidt Group's Growth Strategy Post-Merger Unveiled

Updated Category News Views 218

Aebi Schmidt Group's Strategic Vision After Merger Aebi Schmidt Group is actively trading under the ticker symbol "AEBI" after completing an exciting merger with The Shyft Group. The organization is well-positioned with a robust balance sheet, focusing on executing its post-merger strategies effectively. Amidst a dynamic operating environment, the company's commitment to...

Continue Reading
Unibail-Rodamco-Westfield Achieves Top ‘A’ Rating in Sustainability

Updated Category News Views 373

Unibail-Rodamco-Westfield's Commitment to Sustainability Unibail-Rodamco-Westfield, often abbreviated as URW, has accomplished an impressive feat by receiving a top ‘A’ rating from CDP for the seventh consecutive year. This recognition is a testament to the company's continuous efforts and transparent actions in combating climate change, all structured under its...

Continue Reading
Genstar Capital Hires Industry Veteran John Kufner for Advisory

Updated Category News Views 280

Big Moves in Private Equity: Genstar's New Addition What’s the deal here? Genstar Capital, that powerhouse in private equity, just scored big by bringing John Kufner on board as part of their Strategic Advisory Board. This isn’t just another hire; it's a strategic chess move. Kufner isn’t your run-of-the-mill executive—he's been around the block more than a few...

Continue Reading